Antigen–antibody binding on a plate, enzyme-linked detection antibody → color
HIV, hepatitis, Lyme screen, autoantibodies, hCG
High sensitivity; confirm positives with a specific test
Electrophoresis by size → transfer → antibody probe
Lyme confirmation (after ELISA)
Replaced for HIV by differentiation assay
Direct immunofluorescence
Labeled anti-human Ig/C3 applied to patient tissue
Glomerulonephritis, bullous disease, vasculitis
Linear (anti-GBM, pemphigoid) · granular (immune complex) · intercellular net (pemphigus)
Indirect immunofluorescence
Patient serum on cells/tissue, then labeled anti-human Ig
ANA (HEp-2), ANCA (c- cytoplasmic, p- perinuclear)
ANA pattern hints at target (homogeneous → dsDNA/histone; centromere)
Cells tagged with fluorescent anti-CD antibodies pass a laser
CD4 count, lymphoma/leukemia typing, PNH (CD55/59, FLAER), LAD (CD18), CGD (DHR)
Measures surface (and some intracellular) markers
Anti-human globulin added to patient RBCs → agglutination if coated
AIHA, hemolytic transfusion reaction, HDFN
Warm (IgG) vs cold (C3) pattern
Patient serum + reagent RBCs → detect free antibodies
Antibody screen before transfusion, prenatal Rh testing
—
C3, C4 (consumption); CH50 (classical), AH50 (alternative) function
SLE activity, cryoglobulinemia, complement deficiency, HAE (↓ C4)
Acute-phase rise can mask consumption
SPEP · immunofixation · free light chains
Separate serum proteins; identify monoclonal heavy/light chain
Myeloma, MGUS, Waldenström, AL amyloid
Abnormal κ:λ ratio = clonal
IGRA · tuberculin skin test
IFN-γ release by T cells to TB antigens (ESAT-6, CFP-10) · DTH reaction
Latent TB screening
IGRA not affected by BCG · both falsely negative in immunosuppression
Agglutination · precipitation
Antibody cross-links particles · soluble complexes
Blood typing, latex tests (Cryptococcus antigen), Monospot
Prozone effect with antibody excess
Amplifies nucleic acid
HIV viral load, chlamydia/gonorrhea, HSV in CSF
Detects nucleic acid, not viability